HLX in AML: novel prognostic and therapeutic target

por Pandolfi, Ashley, Steidl, Ulrich
Publicado em 2012

Concise Review: Preleukemic Stem Cells: Molecular Biology and Clinical Implications of the Precursors to Leukemia Stem Cells

por Pandolfi, Ashley, Barreyro, Laura, Steidl, Ulrich
Publicado em 2013

CD8(+) T cell concentration determines their efficiency in killing cognate antigen–expressing syngeneic mammalian cells in vitro and in mouse tissues

por Budhu, Sadna, Loike, John D., Pandolfi, Ashley, Han, Soo, Catalano, Geoffrey, Constantinescu, Andrei, Clynes, Raphael, Silverstein, Samuel C.
Publicado em 2010

PAK1 is a therapeutic target in acute myeloid leukemia and myelodysplastic syndrome

por Pandolfi, Ashley, Stanley, Robert F., Yu, Yiting, Bartholdy, Boris, Pendurti, Gopichand, Gritsman, Kira, Boultwood, Jacqueline, Chernoff, Jonathan, Verma, Amit, Steidl, Ulrich
Publicado no Blood (2015)

H2.0-like homeobox (HLX) regulates early hematopoiesis and promotes acute myeloid leukemia

por Kawahara, Masahiro, Pandolfi, Ashley, Bartholdy, Boris, Barreyro, Laura, Will, Britta, Roth, Michael, Okoye-Okafor, Ujunwa C., Todorova, Tihomira I., Figueroa, Maria E., Melnick, Ari, Mitsiades, Constantine S., Steidl, Ulrich
Publicado em 2012

Satb1 regulates hematopoietic stem cell self-renewal by promoting quiescence and repressing differentiation commitment

por Will, Britta, Vogler, Thomas O., Bartholdy, Boris, Garrett-Bakelman, Francine, Mayer, Jillian, Barreyro, Laura, Pandolfi, Ashley, Todorova, Tihomira I., Okoye-Okafor, Ujunwa C., Stanley, Robert F., Bhagat, Tushar D., Verma, Amit, Figueroa, Maria E., Melnick, Ari, Roth, Michael, Steidl, Ulrich
Publicado em 2013